U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07689331) titled 'Hungarian National Systemic Amyloidosis Registry' on May 29.
Brief Summary: This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.
Study Start Date: March 08
Study Type: OBSERVATIONAL
Condition:
Systemic Amyloidosis
ATTR Amyloidosis
AL Amyloidosis
Amyloid Cardiomyopathy
Recruitment Status: RECRUITING
Sponsor: Semmelweis University
Information provided b...